HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of intratumoral OK-432 administration of thymidine phosphorylase expression in human gastric carcinoma.

Abstract
It is known that thymidine phosphorylase (dThdPase) is increased in various types of malignant tumors and is induced by cytokines. In this study, we have investigated the effects of OK-432, which induces multiple cytokines, on dTHdPase expression and angiogenesis in human gastric carcinomas. We examined 25 patients who underwent gastrectomy for gastric carcinoma. OK-432 was directly injected in tumors in 16 (OK group) of 25 patients via endoscopy before operation and the other 9 patients were not treated (control group). The dThdPase activity in carcinoma tissues of the OK group was significantly higher than that of the control group (P < 0.05). The amounts of IL-1 alpha, IFN-alpha, and IFN-gamma in carcinomas in the OK group were significantly higher than in the controls (P < 0.05), and these were significantly correlated with the dThdPase activity. Intratumoral OK-432 administration enhances the expression of dThdPase in gastric carcinoma cells by inducing various cytokines.
AuthorsK Ogawa, S Konno, Y Takebayashi, M Murayama, T Shimakawa, T Katsube, Y Naritaka, T Kajiwara, M Aiba, S Akiyama
JournalAnticancer research (Anticancer Res) 2001 Mar-Apr Vol. 21 Issue 2B Pg. 1257-62 ISSN: 0250-7005 [Print] Greece
PMID11396196 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Interferon-alpha
  • Interleukin-1
  • Picibanil
  • Interferon-gamma
  • Thymidine Phosphorylase
Topics
  • Antineoplastic Agents (administration & dosage, therapeutic use)
  • Capillaries
  • Female
  • Humans
  • Interferon-alpha (biosynthesis)
  • Interferon-gamma (biosynthesis)
  • Interleukin-1 (biosynthesis)
  • Male
  • Middle Aged
  • Picibanil (administration & dosage, therapeutic use)
  • Stomach Neoplasms (drug therapy, enzymology, pathology)
  • Thymidine Phosphorylase (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: